Steroid derivative regulators, method for preparing the same, and uses thereof
US-2022017565-A1 · Jan 20, 2022 · US
US11214591B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11214591-B2 |
| Application number | US-201916576406-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 19, 2019 |
| Priority date | Sep 19, 2018 |
| Publication date | Jan 4, 2022 |
| Grant date | Jan 4, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure provides for a synthetic strategy to incorporate a C12α-hydroxy group from the methylene (—CH2-) in a steroid backbone, combining synthetic chemistry and enzymology techniques to develop a selective inhibitor for cytochrome P450 8B1, and developing a selective P450 8B1 inhibitor, which can be used as a tool to study P450 8B1 and treat health issues.
Opening claim text (preview).
The invention claimed is: 1. A compound having a general formula (I) or a pharmaceutically acceptable salt thereof: 2. A compound having a general formula (II) or a pharmaceutically acceptable salt thereof: 3. The general formula of claim 1 , wherein the general formula is reductively animated to produce at least one derivative. 4. The at least one derivative of claim 3 , wherein the derivative is a 12-dimethylamino derivative. 5. The at least one derivative of claim 3 , wherein the derivative is a substrate of P450 8B1. 6. A pharmaceutical composition comprising the compound of claim 1 . 7. The general formula of claim 2 , wherein the general formula is reductively animated to produce at least one derivative. 8. The at least one derivative of claim 7 , wherein the derivative is a 12-dimethylamino derivative. 9. The at least one derivative of claim 7 , wherein the derivative is a substrate of P450 8B1. 10. A pharmaceutical composition comprising the compound of claim 2 .
Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane · CPC title
not condensed · CPC title
Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00 · CPC title
containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton · CPC title
the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.